← All trials
NCT06155994
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 20, 2021
- Primary completion
- Jun 30, 2023
- Completion date
- Jun 30, 2023
- First posted
- Dec 5, 2023
- Last posted
- Dec 5, 2023
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Medical University InnsbruckLead sponsor
- Medical University InnsbruckOverall official - principal investigator
- Medical University InnsbruckOfficial
- NovartisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.